Celadon Pharmaceuticals Plc is a UK based pharmaceutical company focused on the research, cultivation, manufacturing, and supply of breakthrough cannabis-based medicines. Founded in 2018 after cannabis was legalised for medicinal purposes, Celadon was one of the first companies to receive Home Office and MHRA licences to cultivate and produce high-THC medicines. In March 2022, Celadon listed on the AIM market of the London Stock Exchange – a huge milestone in the industry and the first since GW Pharma (who were acquired for $7bn by Jazz in 2021).
The Company has a clear mission: to improve quality of life for patients most in need through breakthrough cannabis-based medicines. The primary focus is addressing the 8 million chronic pain sufferers in the UK, who currently have little alternative to opioids.
Celadon has a 100,000 sq ft facility in the UK, comprising a large indoor hydroponic cultivation area, proprietary extraction and GMP standard API manufacturing, and an R&D and testing laboratory. It has been estimated by Canaccord that it would cost a new market entrant over £60m and 2-3 years minimum to replicated what Celadon has built in the UK.
The Company's subsidiary, LVL Health, owns an MHRA conditionally approved clinical trial using cannabis-based medicines to treat chronic pain in the UK. The initial study is already live and interested patients can learn more here: www.lvlhealth.co.uk
Moreover, Celadon has a 20% stake in Kingdom Therapeutics, an early-stage biopharma developed a licenced cannabinoid medicine for children with Autism Spectrum Disorder. This forms part of Celadon’s ‘Breakthrough R&D’ programme, which aims to develop novel IP (molecules, delivery technology) and the future of cannabis-based medicines.
Learn more about Celadon here: www.celadonpharma.com
Company Details
- Employees
- 18
- Founded
- -
- Address
- 71-75 Shelton Street, Covent Garden, London,london Wc2h 9jq,united Kingdom
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.celadonpharma.com
- Keywords
- Biotechnology, Pharmaceuticals, Drug Discovery, GMP, Drug Manufacturing, Compound Discovery, Cannabinoids, Cannabis.
- HQ
- London, London
Celadon Pharmaceuticals Questions
Celadon Pharmaceuticals's website is http://www.celadonpharma.com
Celadon Pharmaceuticals's LinkedIn profile is https://uk.linkedin.com/company/celadon-pharma-plc
Celadon Pharmaceuticals has
18 employees.
View email and phone details for 18
employees at Celadon Pharmaceuticals.
Celadon Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Celadon Pharmaceuticals's top competitors are
Curaleaf Laboratories,
Jazz Pharmaceuticals,
Somaí,
Gw Pharmaceuticals Plc,
Valeos Pharma A/s,
Kingdom Therapeutics Ltd,
Glass Pharms,
Phytome Life Sciences,
Nogra Pharma,
Dalgety.
Celadon Pharmaceuticals's categories are Pharmaceutical Manufacturing
Celadon Pharmaceuticals's founding year is 2018
